egfr

     

Users that searched for egfr

Tweets about egfr

  • EGFR inhibition by anti-CD147 therapy in Cutaneous Squamous cell Carcinoma.
  • RT @oncologytube: EGFR TKIs, their congeners and partners: Can we improve outcome?
  • Últimos datos de SG en CPNM EGFR+
  • Dr. Wu #ESMO14 - EGFR mutation/survival outcomes in pts w/ completely resected lung adenocarcinoma (ICAN trial)
  • Dr. Lynch from @YNHH built a career united around two abiding goals of clinical discovery & personalized patient care
  • 'Iressa' (AstraZeneca) incluirá las pruebas en sangre de mutaciones EGFR en la ficha técnica europea
  • All pts with mCRC should undergo RAS mutation testing to ensure optimal selection for EGFR inhibitor therapy #esmo14
  • EGFR TKIs, their congeners and partners: Can we improve outcome?
  • 推定糸球体ろ過量(eGFR)が10ml/分以下では人工透析が必要だ。
  • EGFR Kkkkkkkkpl. Ukkkkkk cgjjnn
  • EGFR inhibition by anti-CD147 therapy in Cutaneous Squamous cell Carcinoma: EGFR inhibition by anti-CD147 ther...
  • AZD9291
  • RT @sgoncos: "Erlotinib alone or w/ BEVA as first-line Tx in pts w/ non-squamous NSCLC harbouring EGFR mutations phase 2 :Lancet
  • The tumor suppressor genes are:pRB, P53, myc, , EGFR or C-erbB1, ras, E-cadherin
  • In NSCLC, Stop Targeted Tx When Chemo Begins (CME/CE) (MedPage Today) -- No benefit seen for continuing EGFR inhib...
  • In NSCLC, Stop Targeted Tx When Chemo Begins (CME/CE): (MedPage Today) -- No benefit seen for continuing EGFR ...
  • (MedPage Today) -- No benefit seen for continuing EGFR inhibitor treatment in resistant disease.
  • In NSCLC, Stop Targeted Tx When Chemo Begins (CME/CE) (MedPage Today) -- No benefit seen for continuing EGFR inh...
  • EGFR Pioneer Keeps Focus on Individualizing Patient Care in Lab and Clinic
  • "Erlotinib alone or w/ BEVA as first-line Tx in pts w/ non-squamous NSCLC harbouring EGFR mutations phase 2 :Lancet
  • EGFR Pioneer Keeps Focus on Individualizing Patient Care in Lab and Clinic #oncology
  • EGFR has a tumourpromoting role in liver macrophages during hepatocellular carcinomaÂformation
. ,